Literature DB >> 27389601

[Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease].

F Marxreiter1, A Storch2,3, J Winkler4.   

Abstract

Parkinson's disease (PD) is the most common age-related movement disorder and characterized by slowly progressive neurodegeneration resulting in motor symptoms, such as bradykinesia, rigidity, tremor and postural instability. Moreover, non-motor symptoms, such as hyposmia, anxiety and depression reduce the quality of life in PD. Motor symptoms are associated with a distinct striatal dopaminergic deficit resulting from axonal dysfunction and neuronal loss in the substantia nigra (SN). Recent progress in stem cell technology allows the optimization of cellular transplantation strategies in order to alleviate the motor deficit, which potentially leads to a reactivation of this therapeutic strategy. Besides neurodegenerative processes impaired adult neurogenesis and consequentially reduced endogenous cellular plasticity may play an important role in PD. This article discusses the notion that non-motor symptoms in PD may partly be explained by reduced adult neurogenesis in the olfactory bulb and hippocampus.

Entities:  

Keywords:  Hippocampus; Neural stem cells; Neurodegeneration; Olfactory bulb; Transplantation

Mesh:

Year:  2016        PMID: 27389601     DOI: 10.1007/s00115-016-0157-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  76 in total

1.  Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain.

Authors:  H G Kuhn; J Winkler; G Kempermann; L J Thal; F H Gage
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 2.  Cognitive decline correlates with neuropathological stage in Parkinson's disease.

Authors:  Heiko Braak; Udo Rüb; Kelly Del Tredici
Journal:  J Neurol Sci       Date:  2006-06-30       Impact factor: 3.181

Review 3.  Cell-to-cell transmission of non-prion protein aggregates.

Authors:  Seung-Jae Lee; Paula Desplats; Christina Sigurdson; Igor Tsigelny; Eliezer Masliah
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

4.  Reduced neurogenesis and pre-synaptic dysfunction in the olfactory bulb of a rat model of depression.

Authors:  D Yang; Q Li; L Fang; K Cheng; R Zhang; P Zheng; Q Zhan; Z Qi; S Zhong; P Xie
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

5.  Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain.

Authors:  M Biebl; C M Cooper; J Winkler; H G Kuhn
Journal:  Neurosci Lett       Date:  2000-09-08       Impact factor: 3.046

6.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

7.  Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.

Authors:  Katsuaki Suzuki; Kyoko Okada; Tomoyasu Wakuda; Chie Shinmura; Yosuke Kameno; Keiko Iwata; Taro Takahashi; Shiro Suda; Hideo Matsuzaki; Yasuhide Iwata; Kenji Hashimoto; Norio Mori
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

8.  Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.

Authors:  Franz Marxreiter; Benjamin Ettle; Verena E L May; Hakan Esmer; Christina Patrick; Christine Lund Kragh; Jochen Klucken; Beate Winner; Olaf Riess; Jürgen Winkler; Eliezer Masliah; Silke Nuber
Journal:  Neurobiol Dis       Date:  2013-07-16       Impact factor: 5.996

9.  Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice.

Authors:  M Yamada; M Onodera; Y Mizuno; H Mochizuki
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.